Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€177.80
01.12.19
€300.00
04.11.21
49.94%
29.04.21

Could be worthwhile Investment >10% per year
MicroVision Inc

Start price
Target price
Perf. (%)
€24.88
27.04.21
€20.00
27.04.22
-24.96%
27.04.21

Capable Management
Probably not worthwhile Investment
Few uniques
Teleflex Inc.

Start price
Target price
Perf. (%)
€320.00
21.02.21
-
21.02.22
14.38%
23.04.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€62.50
24.02.21
-
24.02.22
1.60%
30.03.21

Probably not worthwhile Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€12.90
17.10.20
-
04.11.21
-29.07%
24.03.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€24.00
08.03.21
€15.00
08.03.22
32.50%
20.03.21

Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.22
21.02.21
-
21.02.22
-5.21%
06.03.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
CRH Medical Corp

Start price
Target price
Perf. (%)
€3.22
08.02.21
€3.00
08.02.22
-0.62%
22.02.21

Good culture
Probably not worthwhile Investment
Little innovation
No uniques
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€7.35
08.02.21
€9.00
08.02.22
-1.36%
22.02.21

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.12
08.02.21
€5.00
08.02.22
14.10%
22.02.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.44
08.02.21
€5.00
08.02.22
-27.31%
22.02.21

Could be worthwhile Investment >10% per year
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€132.95
05.02.21
€100.00
-10.68%
21.02.21

Risky Investment
buy
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€137.50
06.02.21
-
06.02.22
-10.00%
19.02.21

Could be very worthwhile Investment >20% year
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€219.23
21.01.21
€215.00
2.46%
15.02.21

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.03
29.01.21
€34.00
29.04.21
-5.94%
08.02.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€7.55
25.01.21
€10.00
25.01.22
-2.65%
08.02.21

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€36.75
25.01.21
€50.00
25.01.22
-12.24%
08.02.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€2.10
25.01.21
€3.00
25.01.22
63.56%
08.02.21

Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€33.80
02.02.21
€30.00
16.02.21
0.27%
02.02.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.29
21.12.20
€42.00
-3.06%
01.02.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.13
11.01.21
€50.00
11.01.22
-5.37%
29.01.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.79
11.01.21
€2.00
11.01.22
166.14%
25.01.21

Could be worthwhile Investment >10% per year